Antibiotic-Eluting Envelopes to Prevent Cardiac-Implantable Electronic Device Infection: Past, Present, and Future

Area of Science:

• Cardiology
• Infectious Diseases
• Biomaterials Science

Background:

• Cardiac-implantable electronic device (CIED) infections lead to significant patient morbidity and mortality.
• Staphylococci are the primary cause of CIED infections, often originating from contamination during implantation.
• Current strategies, like extended systemic antibiotic therapy, have shown limited efficacy in preventing CIED infections.

Purpose of the Study:

• To review the risk factors and pathogenesis of CIED infections.
• To evaluate the rationale and evidence for using antibiotic-eluting envelopes (ABEs) in high-risk patients.
• To discuss the benefits of ABEs in preventing CIED pocket infections.

Main Methods:

• Review of existing literature on CIED infections and ABEs.
• Analysis of clinical trial data for ABE efficacy.
• Comparison of different ABE technologies and materials.

Main Results:

• Antibiotic-eluting envelopes (ABEs) reduce CIED pocket infections by providing sustained local antibiotic delivery.
• One ABE (TYRX™) demonstrated reduced infections in a large randomized trial.
• Another ABE (CanGaroo-G™) utilizes decellularized extracellular matrix for improved tissue integration and local antibiotic delivery.

Conclusions:

• ABE devices are beneficial in reducing CIED pocket infections through localized antibiotic prophylaxis.
• Given the rising incidence of CIEDs and infections, innovative prevention methods like ABEs are crucial.
• Further research into biomaterial-based solutions for CIED infection prevention is warranted.